Cargando…
A Single-Institute Experience with C-ros Oncogene 1 Translocation in Non-Small Cell Lung Cancers in Taiwan
(1) Background: The C-ros oncogene 1 (ROS1) gene translocation is an important biomarker for selecting patients for crizotinib-targeted therapy. The aim of this study was to understand the incidence, diagnostic algorithm, clinical course and objective response to crizotinib in ROS1 translocated lung...
Autores principales: | Wang, Hsiang-Sheng, Liu, Chien-Ying, Hsu, Sheng-Chi, Huang, Shih-Chiang, Hung, Tsai-Hsien, Ng, Kwai-Fong, Chen, Tse-Ching |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9145855/ https://www.ncbi.nlm.nih.gov/pubmed/35628598 http://dx.doi.org/10.3390/ijms23105789 |
Ejemplares similares
-
Population genetic diversity and structure of Rhinogobius candidianus (Gobiidae) in Taiwan: Translocation and release
por: Kang, Bin, et al.
Publicado: (2022) -
Composite hepatocellular carcinoma and small cell carcinoma with early nodal metastasis: A case report
por: Liu, Yu-Jen, et al.
Publicado: (2017) -
Role of ADGRG1/GPR56 in Tumor Progression
por: Ng, Kwai-Fong, et al.
Publicado: (2021) -
Cancer Incidence among Heart, Kidney, and Liver Transplant Recipients in Taiwan
por: Lee, Kwai-Fong, et al.
Publicado: (2016) -
Transplant Recipients Using Tacrolimus Had Higher Utilization of Healthcare Services Than Those Receiving Cyclosporine in Taiwan
por: Lin, Yi-Chang, et al.
Publicado: (2019)